P-cadherin expression in Merkel cell carcinomas is associated with prolonged recurrence-free survival

British Journal of Dermatology

Volumn 166, Issue 5, 2012, Pages 1043-1052

  Vlahova, L ^a   Doerflinger, Y ^a   Houben, R ^b   Becker, J C ^c   Schrama, D ^c   Weiss, C ^d   Goebeler, M ^b,e   Helmbold, P ^d   Goerdt, S ^a   Peitsch, W K ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE CELL ADHESION MOLECULE; P CADHERIN; PARAFFIN; UVOMORULIN; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MERKEL CELL POLYOMAVIRUS; MERKEL CELL TUMOR; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SAMPLE; VIRUS DETECTION;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, MERKEL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SKIN NEOPLASMS;

EID: 84860348379     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10853.x     Document Type: Article

References (57)

1. Schrama D, Becker JC,. Merkel cell carcinoma-pathogenesis, clinical aspects and treatment. J Eur Acad Dermatol Venereol 2011; 25: 1121-9.
2. Nicolaidou E, Mikrova A, Antoniou C, Katsambas AD,. Advances in Merkel cell carcinoma pathogenesis and management: a recently discovered virus, a new international consensus staging system and new diagnostic codes. Br J Dermatol 2012; 166: 16-21.
3. Hodgson NC,. Merkel cell carcinoma: changing incidence trends. J Surg Oncol 2005; 89: 1-4. (Pubitemid 40075960)
4. Moll R, Lowe A, Laufer J, et al. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992; 140: 427-47.
5. Bobos M, Hytiroglou P, Kostopoulos I, et al. Immunohistochemical distinction between Merkel cell carcinoma and small cell carcinoma of the lung. Am J Dermatopathol 2006; 28: 99-104. (Pubitemid 44270868)
6. Lemos BD, Storer BE, Iyer JG, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010; 63: 751-61.
7. Tai P,. Merkel cell cancer: update on biology and treatment. Curr Opin Oncol 2008; 20: 196-200. (Pubitemid 351317408)
8. Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319: 1096-100. (Pubitemid 351300792)
9. Kassem A, Schöpflin A, Diaz C, et al. Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res 2008; 68: 5009-13.
10. Becker JC, Houben R, Ugurel S, et al. MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J Invest Dermatol 2009; 129: 248-50.
11. Garneski KM, Warcola AH, Feng Q, et al. Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumours. J Invest Dermatol 2009; 129: 246-8.
12. Sastre-Garau X, Peter M, Avril MF, et al. Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis. J Pathol 2009; 218: 48-56.
13. Houben R, Shuda M, Weinkam R, et al. Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol 2010; 84: 7064-72.
14. Houben R, Adam C, Baeurle A, et al. An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells. Int J Cancer 2012; 130: 847-56.
15. Shuda M, Kwun HJ, Feng H, et al. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J Clin Invest 2011; 121: 3623-34.
16. Paulson KG, Carter JJ, Johnson LG, et al. Antibodies to Merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in Merkel cell carcinoma patients. Cancer Res 2010; 70: 8388-97.
17. Moll I, Roessler M, Brandner JM, et al. Human Merkel cells-aspects of cell biology, distribution and functions. Eur J Cell Biol 2005; 84: 259-71. (Pubitemid 40353067)
18. Lucarz A, Brand G,. Current considerations about Merkel cells. Eur J Cell Biol 2007; 86: 243-51. (Pubitemid 46630212)
19. Van Keymeulen A, Mascre G, Youseff KK, et al. Epidermal progenitors give rise to Merkel cells during embryonic development and adult homeostasis. J Cell Biol 2009; 187: 91-100.
20. Niessen CM, Gottardi CJ,. Molecular components of the adherens junction. Biochim Biophys Acta 2008; 1778: 562-71.
21. Wheelock MJ, Shintani Y, Maeda M, et al. Cadherin switching. J Cell Sci 2008; 121: 727-35. (Pubitemid 351578108)
22. Werling AM, Doerflinger Y, Brandner JM, et al. Homo- and heterotypic cell-cell contacts in Merkel cells and Merkel cell carcinomas: heterogeneity and indications for cadherin switching. Histopathology 2011; 58: 286-303.
23. Schrama D, Peitsch WK, Zapatka M, et al. Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma. J Invest Dermatol 2011; 131: 1631-8.
24. Fischer N, Brandner J, Fuchs F, et al. Detection of Merkel cell polyomavirus (MCPyV) in Merkel cell carcinoma cell lines: cell morphology and growth phenotype do not reflect presence of the virus. Int J Cancer 2010; 126: 2133-42.
25. Helmbold P, Lahtz C, Enk A, et al. Frequent occurrence of RASSF1A promoter hypermethylation and Merkel cell polyomavirus in Merkel cell carcinoma. Mol Carcinog 2009; 48: 903-9.
26. Tanaka Y, Sano T, Qian ZR, et al. Expression of adhesion molecules and cytokeratin 20 in Merkel cell carcinomas. Endocr Pathol 2004; 15: 117-29. (Pubitemid 39185862)
27. Panelos J, Batistatou A, Paglierani M, et al. Expression of Notch-1 and alteration of the E-cadherin/beta-catenin cell adhesion complex are observed in primary cutaneous neuroendocrine carcinoma (Merkel cell carcinoma). Mod Pathol 2009; 22: 959-68.
28. Han AC, Soler AP, Tang CK, et al. Nuclear localization of E-cadherin expression in Merkel cell carcinoma. Arch Pathol Lab Med 2000; 124: 1147-51. (Pubitemid 30654805)
29. Molès JP, Watt FM,. The epidermal stem cell compartment: variation in expression levels of E-cadherin and catenins within the basal layer of human epidermis. J Histochem Cytochem 1997; 45: 867-74. (Pubitemid 27248802)
30. Jamora C, DasGupta R, Kocieniewski P, Fuchs E,. Links between signal transduction, transcription and adhesion in epithelial bud development. Nature 2003; 422: 317-22. (Pubitemid 36378359)
31. Rhee H, Polak L, Fuchs E,. Lhx2 maintains stem cell character in hair follicles. Science 2006; 312: 1946-9. (Pubitemid 43993720)
32. Berx G, van Roy F,. Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol 2009; 1: a003129.
33. Li G, Satyamoorthy K, Herlyn M,. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res 2001; 61: 3819-25. (Pubitemid 32694999)
34. Qi J, Chen N, Wang J, Siu CH,. Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway. Mol Biol Cell 2005; 16: 4386-97. (Pubitemid 41262905)
35. Augustine CK, Yoshimoto Y, Gupta M, et al. Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment. Cancer Res 2008; 68: 3777-84.
36. Beasley GM, Riboh JC, Augustine CK, et al. Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma. J Clin Oncol 2011; 29: 1210-15.
37. Perl AK, Wilgenbus P, Dahl U, et al. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998; 392: 190-3. (Pubitemid 28162793)
38. van Roy F, Berx G,. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 2008; 65: 3756-88.
39. Yoshida S, Furukawa N, Haruta S, et al. Expression profiles of genes involved in poor prognosis of epithelial ovarian carcinoma: a review. Int J Gynecol Cancer 2009; 19: 992-7.
40. Charafe-Jauffret E, Tarpin C, Viens P, Bertucci F,. Defining the molecular biology of inflammatory breast cancer. Semin Oncol 2008; 35: 41-50. (Pubitemid 351282395)
41. Chang SH, Worley LA, Onken MD, Harbour JW,. Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis. Melanoma Res 2008; 18: 191-200. (Pubitemid 351684664)
42. Van Marck V, Stove C, Van Den Bossche K, et al. P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma. Cancer Res 2005; 65: 8774-83. (Pubitemid 41379401)
43. Van Marck V, Stove C, Jacobs K, et al. P-cadherin in adhesion and invasion: opposite roles in colon and bladder carcinoma. Int J Cancer 2011; 128: 1031-44.
44. Taniuchi K, Nakagawa H, Hosokawa M, et al. Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases. Cancer Res 2005; 65: 3092-9. (Pubitemid 40524589)
45. Paredes J, Albergaria A, Oliveira JT, et al. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin Cancer Res 2005; 11: 5869-77. (Pubitemid 41170315)
46. Paredes J, Correia AL, Ribeiro AS, et al. P-cadherin expression in breast cancer: a review. Breast Cancer Res 2007; 9: 214.
47. Sun L, Hu H, Peng L, et al. P-cadherin promotes liver metastasis and is associated with poor prognosis in colon cancer. Am J Pathol 2011; 179: 380-90.
48. Hibi K, Goto T, Mizukami H, et al. Demethylation of the CDH3 gene is frequently detected in advanced colorectal cancer. Anticancer Res 2009; 29: 2215-17.
49. Lo Muzio L, Campisi G, Farina A, et al. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study. BMC Cancer 2005; 5: 63.
50. Mandeville JA, Silva Neto B, Vanni AJ, et al. P-cadherin as a prognostic indicator and a modulator of migratory behaviour in bladder carcinoma cells. BJU Int 2008; 102: 1707-14.
51. Bauer R, Wild PJ, Meyer S, et al. Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays. J Clin Pathol 2006; 59: 699-705. (Pubitemid 44048777)
52. Bachmann IM, Straume O, Puntervoll H, et al. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clin Cancer Res 2005; 11: 8606-14. (Pubitemid 43005907)
53. Bauer R, Bosserhoff AK,. Functional implication of truncated P-cadherin expression in malignant melanoma. Exp Mol Pathol 2006; 81: 224-30. (Pubitemid 44687436)
54. Ribeiro AS, Albergaria A, Sousa B, et al. Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells. Oncogene 2010; 29: 392-402.
55. Bauer K, Dowejko A, Bosserhoff AK, et al. P-cadherin induces an epithelial-like phenotype in oral squamous cell carcinoma by GSK-3beta-mediated Snail phosphorylation. Carcinogenesis 2009; 30: 1781-8.
56. Yilmaz M, Christofori G,. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009; 28: 15-33.
57. Wells A, Chao YL, Grahovac J, et al. Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis. Front Biosci 2011; 16: 815-37.